Skip to main content

Table 2 Exosomal microRNA as diagnostic and prognostic biomarkers in HCC

From: Exosomal microRNAs in hepatocellular carcinoma

Exosomal microRNA as biomarkers Biofluid Clinical significance References
exo-miR-215-5p Serum Overexpression predicts poor disease-free survival in patients with HCC [117]
miR-10b-5p Serum Potential biomarker for early-stage HCC [117]
miR-18a, miR-221, miR-222, miR-224, miR-101, miR-106b, miR-122, miR195 Serum Novel serological biomarkers for HCC [43]
miR-122, miR-148a and AFP Serum Distinguish early HCC from liver cirrhosis [41]
miR-122 Serum Distinguish HCC from normal control [41]
miR-9-3p Serum A therapeutic target for HCC [69]
miR-665 Serum A novel minimally invasive biomarker for HCC diagnosis and prognosis [70]
miR-21 Serum A potential biomarker for HCC diagnosis. [40]